Centiva Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
13,689
-2,343
| -15% | -$252K | 0.02% | 257 |
|
|
2025
Q1 | $1.62M | Buy |
16,032
+7,871
| +96% | +$794K | 0.05% | 163 |
|
|
2024
Q4 | $729K | Sell |
8,161
-6,843
| -46% | -$611K | 0.02% | 431 |
|
|
2024
Q3 | $1.26M | Sell |
15,004
-4,536
| -23% | -$380K | 0.02% | 395 |
|
|
2024
Q2 | $1.5M | Buy |
+19,540
| New | +$1.5M | 0.03% | 358 |
|
|
2024
Q1 | – | Sell |
-5,773
| Closed | -$334K | – | 1400 |
|
|
2023
Q4 | $334K | Buy |
5,773
+3,714
| +180% | +$215K | 0.01% | 739 |
|
|
2023
Q3 | $109K | Sell |
2,059
-28,726
| -93% | -$1.52M | ﹤0.01% | 1039 |
|
|
2023
Q2 | $1.67M | Buy |
30,785
+28,114
| +1,053% | +$1.52M | 0.04% | 238 |
|
|
2023
Q1 | $134K | Sell |
2,671
-16,039
| -86% | -$802K | ﹤0.01% | 916 |
|
|
2022
Q4 | $866K | Buy |
+18,710
| New | +$866K | 0.02% | 341 |
|
|
2022
Q3 | – | Sell |
-10,585
| Closed | -$395K | – | 1001 |
|
|
2022
Q2 | $395K | Buy |
+10,585
| New | +$395K | 0.01% | 697 |
|
|
2021
Q3 | – | Sell |
-38,999
| Closed | -$1.67M | – | 955 |
|
|
2021
Q2 | $1.67M | Buy |
+38,999
| New | +$1.67M | 0.04% | 175 |
|
|
2019
Q4 | – | Sell |
-53,995
| Closed | -$2.2M | – | 483 |
|
|
2019
Q3 | $2.2M | Buy |
+53,995
| New | +$2.2M | 0.13% | 55 |
|